No Data
No Data
Nuvectis Pharma(NVCT.US) Officer Buys US$3,145 in Common Stock
$Nuvectis Pharma(NVCT.US)$ Officer Poradosu Enrique purchased 500 shares of common stock on May 10, 2024 at an average price of $6.29 for a total value of $3,145.Source: Announcement What is statement
Nuvectis Pharma(NVCT.US) 10% Shareholder Buys US$12,800 in Common Stock
$Nuvectis Pharma(NVCT.US)$ 10% Shareholder BENTSUR RON purchased 2,000 shares of common stock on May 10, 2024 at an average price of $6.4 for a total value of $12,800.Source: Announcement What is stat
Nuvectis Pharma(NVCT.US) Officer Buys US$7,034.16 in Common Stock
$Nuvectis Pharma(NVCT.US)$ Officer Shemesh Shay purchased 1,113 shares of common stock on May 10, 2024 at an average price of $6.32 for a total value of $7,034.16.Source: Announcement What is statemen
Nuvectis Pharma Price Target Maintained With a $21.00/Share by HC Wainwright & Co.
Nuvectis Pharma Price Target Maintained With a $21.00/Share by HC Wainwright & Co.
HC Wainwright & Co. : The Nuvectis Pharma (NVCT.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $21.00.
HC Wainwright & Co. : The Nuvectis Pharma (NVCT.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $21.00.
HC Wainwright & Co. Reiterates Buy on Nuvectis Pharma, Maintains $21 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Nuvectis Pharma (NASDAQ:NVCT) with a Buy and maintains $21 price target.
No Data